Kirchhoff LV, Neva FA: Trypanosoma species (Chagas' disease) , in Mandell GL, Douglas RG Jr, Bennett JE (eds): Principles and Practice of Infectious Diseases , ed 2. New York, John Wiley & Sons Inc, 1984;, pp 1531-1537.
Brener Z: Recent developments in the field of Chagas' disease . Bull WHO 1982;;60:463-473.
Kagan IG, Norman L, Allain D: Studies on Trypanosoma cruzi isolated in the United States: A review . Rev Biol Trop 1966;;14:55-73.
Schiffler RJ, Mansur GP, Navin TR, et al: Indigenous Chagas' disease (American trypanosomiasis) in California . JAMA 1984;;251:2983-2984.
Tabulation of Immigrants Admitted by Country of Birth, 1954-1983 . Immigration and Nationalization Service, US Dept of State, 1984;.
Passel JS, Woodrow KA: Geographic Distribution of Undocumented Immigrants: Estimates of Undocumented Aliens Counted in the 1980 Census by State . Population Division, US Bureau of the Census, 1984;.
Gusmão Rd'A, Rezende JM, Rassi A, et al: Antibody levels to Trypanosoma cruzi in infected patients with and without evidence of chronic Chagas' disease . Am J Trop Med Hyg 1982;;31:452-458.
Camargo ME: Fluorescent antibody test for the diagnosis of American trypanosomiasis: Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo 1966;;8:227-234.
Raizman RE, deRezende JM, Neva FA: A clinical trial with pre- and post-treatment manometry comparing pneumatic dilatation with bouginage for treatment of Chagas' megaesophagus . Am J Gastroenterol 1980;;74:405-409.
Schmuñis GA: Chagas' disease and blood transfusion , in Dodd RY (ed): Infection, Immunity and Blood Transfusion . New York, Alan R Liss Inc, 1985;, pp 101-126.
Amorim D de S: Chagas' disease . Prog Cardiol 1979;;8:235-279.
Wegner DHG, Rohwedder RW: Experience with nifurtimox in chronic Chagas' infection . Arzneimittelforsch 1972;;22:1635-1642.
Brener Z: Present status of chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere . Pharmacol Ther 1979;;7:71-90.
Cançado JR, Marra UD, Lopes M, et al: Toxicidad y valor terapéutico del Bay 2502 en la enfermedad de Chagas crónica en tres esquemas posológicos . Bol Chil Parasitol 1969;;24:28-32.